Advertisement

Ads Placeholder
Loading...

23andMe Holding Co.

MENASDAQ
Healthcare
Medical - Diagnostics & Research
$0.61
$0.00(0.00%)
U.S. Market opens in 19h 17m

23andMe Holding Co. Fundamental Analysis

23andMe Holding Co. (ME) shows weak financial fundamentals with a PE ratio of -0.09, profit margin of -1.35%, and ROE of -7.71%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position238.99%
PEG Ratio-0.01

Areas of Concern

ROE-7.71%
Operating Margin-1.06%
Current Ratio0.81
We analyze ME's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1078.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1078.1/100

We analyze ME's fundamental strength across five key dimensions:

Efficiency Score

Weak

ME struggles to generate sufficient returns from assets.

ROA > 10%
-1.22%

Valuation Score

Excellent

ME trades at attractive valuation levels.

PE < 25
-0.09
PEG Ratio < 2
-0.01

Growth Score

Weak

ME faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ME shows balanced financial health with some risks.

Debt/Equity < 1
0.83
Current Ratio > 1
0.81

Profitability Score

Weak

ME struggles to sustain strong margins.

ROE > 15%
-770.81%
Net Margin ≥ 15%
-1.35%
Positive Free Cash Flow
No

Key Financial Metrics

Is ME Expensive or Cheap?

P/E Ratio

ME trades at -0.09 times earnings. This suggests potential undervaluation.

-0.09

PEG Ratio

When adjusting for growth, ME's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values 23andMe Holding Co. at 0.51 times its book value. This may indicate undervaluation.

0.51

EV/EBITDA

Enterprise value stands at -0.31 times EBITDA. This is generally considered low.

-0.31

How Well Does ME Make Money?

Net Profit Margin

For every $100 in sales, 23andMe Holding Co. keeps $-1.35 as profit after all expenses.

-1.35%

Operating Margin

Core operations generate -1.06 in profit for every $100 in revenue, before interest and taxes.

-1.06%

ROE

Management delivers $-7.71 in profit for every $100 of shareholder equity.

-7.71%

ROA

23andMe Holding Co. generates $-1.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.22%

Following the Money - Real Cash Generation

Operating Cash Flow

23andMe Holding Co. generates limited operating cash flow of $-105.06M, signaling weaker underlying cash strength.

$-105.06M

Free Cash Flow

23andMe Holding Co. generates weak or negative free cash flow of $-107.72M, restricting financial flexibility.

$-107.72M

FCF Per Share

Each share generates $-4.27 in free cash annually.

$-4.27

FCF Yield

ME converts -7.66% of its market value into free cash.

-7.66%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.09

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.51

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.83

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-7.71

vs 25 benchmark

ROA

Return on assets percentage

-1.22

vs 25 benchmark

ROCE

Return on capital employed

-4.20

vs 25 benchmark

How ME Stacks Against Its Sector Peers

MetricME ValueSector AveragePerformance
P/E Ratio-0.0928.45 Better (Cheaper)
ROE-770.81%763.00% Weak
Net Margin-134.69%-45265.00% (disorted) Weak
Debt/Equity0.830.34 Weak (High Leverage)
Current Ratio0.812795.60 Weak Liquidity
ROA-122.09%-16588.00% (disorted) Weak

ME outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 23andMe Holding Co.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ